Viewing Study NCT00310635


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2026-01-26 @ 7:57 PM
Study NCT ID: NCT00310635
Status: COMPLETED
Last Update Posted: 2006-10-26
First Post: 2006-04-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Meningococcal Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prevention of meningococcal infection View